News

Tech investing in France to surpass 2018 by $500 mln

Clarify Medical pulls in $18 mln Series A

San Diego-based medical device company Clarify Medical has secured $18 million in Series A financing. The investors were H.I.G. BioHealth Partners, 7wire Ventures, SV Health Investors and Bluestem Capital.

A2 Biotherapeutics takes in $57 mln Series A

A2 Biotherapeutics, a developer of cell therapies for cancer patients, has raised $57 million in Series A funding. The investors included The Column Group, Vida Ventures, Samsara BioCapital and Nextech Invest.

Coda Biotherapeutics racks up funding

South San Francisco-based Coda Biotherapeutics Inc, a preclinical-stage biopharmaceutical company, has raised a total of $34 million in funding. Versant Ventures was the lead investor in Coda's latest funding round.

Section 32 adds managing partner to team

Section 32 has named Dr. Steven J. Kafka as a managing partner.

Frazier appoints human capital director for life sciences team

Frazier Healthcare Partners named Danica Elliott as a director of human capital for its life sciences team.

PathAI grabs $75 mln Series B

Boston-based PathAI, a provider of AI-powered research tools and services for pathology, has raised $75 million in Series B funding. The investors include Merck Global Health Innovation Fund and Bristol-Myers Squibb.

Healthify picks up $16 mln Series B

New York City-based Healthify, a healthcare company, has raised $16 million in Series B financing. The investors included SV Health Investors and BlueCross BlueShield Venture Partners.

It pays to go direct for OMERS Ventures

The venture capital arm of Ontario Municipal Employees’ Retirement System, is currently investing out of its third vehicle, which closed on C$300m.

Where are they now? Social Capital

We followed up with some of Social Capital's former partners to find out what came of the executives who left the firm.